Cresco Labs (CRLBF) Equity Average (2020 - 2025)
Cresco Labs' Equity Average history spans 6 years, with the latest figure at $364.3 million for Q4 2025.
- For Q4 2025, Equity Average fell 10.73% year-over-year to $364.3 million; the TTM value through Dec 2025 reached $364.3 million, down 10.73%, while the annual FY2025 figure was $364.3 million, 10.73% down from the prior year.
- Equity Average reached $364.3 million in Q4 2025 per CRLBF's latest filing, down from $408.1 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $671.6 million in Q4 2022 to a low of $364.3 million in Q4 2025.
- Average Equity Average over 5 years is $513.3 million, with a median of $507.9 million recorded in 2023.
- Peak YoY movement for Equity Average: surged 86.09% in 2021, then dropped 24.38% in 2023.
- A 5-year view of Equity Average shows it stood at $614.4 million in 2021, then increased by 9.31% to $671.6 million in 2022, then decreased by 24.38% to $507.9 million in 2023, then dropped by 19.64% to $408.1 million in 2024, then decreased by 10.73% to $364.3 million in 2025.
- Per Business Quant, the three most recent readings for CRLBF's Equity Average are $364.3 million (Q4 2025), $408.1 million (Q4 2024), and $507.9 million (Q4 2023).